• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
FENG Feifei, WANG Minghao, HUANG Chunyu, XIE Jun, ZHOU Jianping. Application of k-carrageenan in valsartan immediate-release pellets by extrusion-spheronization[J]. Journal of China Pharmaceutical University, 2015, 46(2): 214-218. DOI: 10.11665/j.issn.1000-5048.20150213
Citation: FENG Feifei, WANG Minghao, HUANG Chunyu, XIE Jun, ZHOU Jianping. Application of k-carrageenan in valsartan immediate-release pellets by extrusion-spheronization[J]. Journal of China Pharmaceutical University, 2015, 46(2): 214-218. DOI: 10.11665/j.issn.1000-5048.20150213

Application of k-carrageenan in valsartan immediate-release pellets by extrusion-spheronization

More Information
  • The aim of the study was to select a suitable pelletisation aid of valsartan immediate-release pellets in the extrusion process and optimized the formulation. The properties of the pellets with five excipients which were microcrystalline cellulose(MCC), low-substituted hydroxypropyl cellulose(L-HPC), crospovidone(PVPP), pregelatinized starch(PCS)and k-carrageenan were evaluated and compared by the single factor test. And the pelletisation aids were chosen preliminary. The properties of the pellets with MCC, L-HPC, k-carrageenan respectively were evaluated and compared and k-carrageenan was determined as the most appropriate pelletisation aid. The Box-Behnken design was employed to optimize the formulation. The optimised formulation was k-carrageenan 16. 98 g, HPMC-E5 2. 03 g, SLS 0. 26 g. The yield and aspect ratio of pellets was 91. 23% and 1. 14, respectively. And there was no significant difference between observed and predictive responses. The results showed k-carrageenan pellets owned properties of a high yield, acceptable sphericity and fast drug release.
  • [1]
    Cao QR, Liu Y, Xu WJ, et al. Enhanced oral bioavailability of novel mucoadhesive pellets containing valsartan prepared by a dry powder-coating technique[J].Int J Pharm,2012,434(1/2):325-333.
    [2]
    Abdul S,Chandewar AV,Jaiswal S B.A flexible technology for modified-release drugs:multiple-unit pellet system(MUPS)[J].J Control Release,2010,147(1):2-16.
    [3]
    Charoenthai N,Kleinebudde P,Puttipipatkhachorn S.Influence of chitosan type on the properties of extruded pellets with low amount of microcrystalline cellulose[J].AAPS PharmSciTech,2007,8(3):E99-E109.
    [4]
    Chopra R,Podczeck F,Newton JM,et al.The influence of pellet shape and film coating on the filling of pellets into hard shell capsules[J].Eur J Pharm Biopharm,2002,53(3):327-33.
    [5]
    Cheng HL,Zou MJ,Wu Y,et al.Preparation and characterization of compound aceclofenac-fast-release pellets by extrusion-spheronization[J].Chin J Pharm(中国药剂学杂志),2011,9(4):63-70.
    [6]
    Dukic-Ott A,Thommes M,Remon JP,et al.Production of pellets via extrusion-spheronisation without the incorporation of microcrystalline cellulose:a critical review[J].Eur J Pharm Biopharm,2009,71(1):38-46.
    [7]
    Markus T,Peter K.Use of k-carrageenan as alternative pelletisation aid to microcrystalline cellulose in extrusion/spheronisation.I.Influence of type and fraction of filler[J].Eur J Pharm Biopharm,2006,63:59-67.
  • Related Articles

    [1]CHU Xuxin, BU Fanxue, YIN Tingjie, HUO Meirong. Antitumor strategies based on targeted modulation of tumor-associated macrophages[J]. Journal of China Pharmaceutical University, 2021, 52(3): 261-269. DOI: 10.11665/j.issn.1000-5048.20210301
    [2]FENG Yang, XU Xiao, MO Ran. Advances in lymphatic targeted drug delivery system for treatment of tumor metastasis[J]. Journal of China Pharmaceutical University, 2020, 51(4): 425-432. DOI: 10.11665/j.issn.1000-5048.20200406
    [3]TANG Keqin, LIN Huaqing, LI Shuhong, DONG Lixin, LU Bohong, JIANG Hong. Advances in tumor targeted nanocrystals[J]. Journal of China Pharmaceutical University, 2020, 51(4): 418-424. DOI: 10.11665/j.issn.1000-5048.20200405
    [4]SONG Ke, PAN Hao, HAN Jiayi, CHEN Lijiang. Nano drug delivery system based strategies to target tumor microenvironment[J]. Journal of China Pharmaceutical University, 2018, 49(4): 392-400. DOI: 10.11665/j.issn.1000-5048.20180402
    [5]CAI Han, LIU Yanhong, YIN Tingjie, ZHOU Jianping, HUO Meirong. Advances in the targeted therapy of tumor-associated fibroblasts[J]. Journal of China Pharmaceutical University, 2018, 49(1): 20-25. DOI: 10.11665/j.issn.1000-5048.20180103
    [6]SUN Jingfang, GUO Chunjing, ZHANG Yunduan, SONG Xiaoyan, LYU Jiantao, YIN Jungang, CHEN Daquan. Preparation and characterization of multi-functional targeting nano-carrier based on pH-redox tumor microenvironment[J]. Journal of China Pharmaceutical University, 2017, 48(3): 305-310. DOI: 10.11665/j.issn.1000-5048.20170309
    [7]SHANG Yunkai, JU Caoyun, XIE Daping, ZHANG Can. Preparation and characterization of tumor targeting doxorubicin liposomesmodified via click chemistry[J]. Journal of China Pharmaceutical University, 2016, 47(6): 708-713. DOI: 10.11665/j.issn.1000-5048.20160613
    [8]XU Yuhong, CAO Jing. Perspectives on targeted nano-drug carriers for tumor treatment[J]. Journal of China Pharmaceutical University, 2013, 44(6): 494-503. DOI: 10.11665/j.issn.1000-5048.20130602
    [9]SHI Yongping, SU Zhigui, XIAO Yanyu, SUN Minjie, PING Qineng, ZONG Li. Preparation and characterization of dual-targeting nanostructure lipid carriers loading mitoxantrone hydrochloride for bone tumor[J]. Journal of China Pharmaceutical University, 2013, 44(4): 321-327. DOI: 10.11665/j.issn.1000-5048.20130407
    [10]Tumor microenvironment:A novel target for antitumor activity of polysaccharides[J]. Journal of China Pharmaceutical University, 2010, 41(1): 1-10.

Catalog

    Article views (1059) PDF downloads (1859) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return